Yu Qian
Head Director, Analytical Project Leads, Cell Therapies Novartis AG
Yu Qian is Director, Head of Analytical Project Leads, Cell Therapies at Novartis, where she leads analytical development strategy supporting cell therapy programs. She previously advanced analytical innovation and product science for cell therapies in leadership roles at Takeda. Yu completed a Postdoc in Cancer Biology and Immunology at Harvard Medical School and earned a Doctor of Philosophy (PhD), Biomedical Science from East China Normal University, specializing in immunology and drug discovery research.
Seminars
Thursday 17th September 2026
Defining Potency in CAR-T & Cell Therapies to Align with FDA Expectations
2:10 pm
- Exploring FDA draft guidance on potency assurance to clarify approaches for demonstrating product functionality and consistency data
- Evaluating matrix and orthogonal potency strategies to ensure robust measurement across diverse patient groups and clinical contexts
